Marta Furtado

Lisbon, 1649028, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Human Induced Pluripotent Stem Cell-Derived Cardioids as a Model to Assess Oligonucleotide Delivery.

Human Induced Pluripotent Stem Cell-Derived Cardioids as a Model to Assess Oligonucleotide Delivery.

Journal: Journal of visualized experiments : JoVE

Published: August 18, 2026

Protocol for generating human iPSC-derived cardiomyocytes using VCAM1-based sorting and micropatterned culture.

Protocol for generating human iPSC-derived cardiomyocytes using VCAM1-based sorting and micropatterned culture.

Journal: STAR protocols

Published: February 04, 2026

Alternative splicing dynamics during human cardiac development in vivo and in vitro.

Alternative splicing dynamics during human cardiac development in vivo and in vitro.

Journal: Stem cell reports

Published: October 08, 2025

Shared splicing dysregulation in heart failure associated with dilated and ischaemic cardiomyopathy and spatial specificity across cardiac regions.

Shared splicing dysregulation in heart failure associated with dilated and ischaemic cardiomyopathy and spatial specificity across cardiac regions.

Journal: Cardiovascular research

Published: July 28, 2025

Shared splicing dysregulation in heart failure associated with dilated and ischemic cardiomyopathy and spatial specificity across cardiac regions.

Shared splicing dysregulation in heart failure associated with dilated and ischemic cardiomyopathy and spatial specificity across cardiac regions.

Journal: Cardiovascular research

Published: July 28, 2025

Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.

Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation.

Journal: Human cell

Published: March 11, 2024

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy.

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy.

Journal: Stem cell research

Published: March 07, 2024

Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations.

Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations.

Journal: Stem cell research

Published: February 01, 2024

Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.

Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying the MYBPC3 missense c.1484G>A mutation.

Journal: Stem cell research

Published: November 03, 2023

Cardiac splicing as a diagnostic and therapeutic target.

Cardiac splicing as a diagnostic and therapeutic target.

Journal: Nature reviews. Cardiology

Published: December 09, 2022

RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy.

RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy.

Journal: International journal of molecular sciences

Published: January 14, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026